Policy Watch: 20 Regulatory Updates — March 20, 2026
Policy WatchMarch 20, 2026. 20 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Federal RegisterSchedules of…
Policy Watch: 10 Regulatory Updates — March 18, 2026
Policy WatchMarch 18, 2026. 10 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Federal RegisterSchedules of…
Policy Watch: 16 Regulatory Updates — March 13, 2026
Policy WatchMarch 13, 2026. 16 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Regulations.govSchedules of…
Policy Watch: 16 Regulatory Updates — March 11, 2026
Policy WatchMarch 11, 2026. 16 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Regulations.govSchedules of…
AM Policy Update: March 11, 2026
AM Policy UpdateMarch 11, 2026. 20 regulatory items from Federal Register, regulations.gov, and regulatory RSS feeds. Score 85Regulations.govSchedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule IThe…